Published in Przegl Lek on January 01, 2006
Safety of enhanced renin-angiotensin-aldosterone system inhibition with aliskiren in nondiabetic patients with chronic kidney disease. Pol Arch Med Wewn (2013) 2.00
Tonic chemoreflex activation contributes to the elevated muscle sympathetic nerve activity in patients with chronic renal failure. J Hypertens (2007) 1.74
Current diagnostic evaluation of autosomal dominant polycystic kidney disease. Pol Arch Med Wewn (2008) 1.10
Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial. Am J Kidney Dis (2008) 1.09
Erythropoietin receptor is expressed on human peripheral blood T and B lymphocytes and monocytes and is modulated by recombinant human erythropoietin treatment. Artif Organs (2010) 1.07
[Modern treatment of autosomal dominant polycystic kidney disease]. Pol Merkur Lekarski (2008) 1.06
Early detection of chronic kidney disease: results of the PolNef study. Am J Nephrol (2008) 0.92
Continuous cognitive improvement 1 year following successful kidney transplant. Kidney Int (2011) 0.92
Effect of pentoxifylline on proteinuria, markers of tubular injury and oxidative stress in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study. Acta Biochim Pol (2010) 0.90
[Hypertensive nephropathy: pathogenesis, diagnosis and treatment]. Pol Merkur Lekarski (2003) 0.89
Immunosenescence increases the rate of acceptance of kidney allotransplants in elderly recipients through exhaustion of CD4+ T-cells. Mech Ageing Dev (2010) 0.88
Serum concentration of amino acids versus nutritional status in hemodialysis patients. J Ren Nutr (2008) 0.86
Cognitive performance before and after kidney transplantation: a prospective controlled study of adequately dialyzed patients with end-stage renal disease. J Int Neuropsychol Soc (2009) 0.85
Direct renin inhibition--a promising strategy for renal protection? Med Sci Monit (2013) 0.84
Remarks on surgical strategy in creating vascular access for hemodialysis: 18 years of one center's experience. Ann Vasc Surg (2005) 0.84
Renal protective effects of the renin-angiotensin-aldosterone system blockade: from evidence-based approach to perspectives. Kidney Blood Press Res (2005) 0.83
Long-term therapy with recombinant human erythropoietin decreases percentage of CD152(+) lymphocytes in primary glomerulonephritis haemodialysis patients. Nephrol Dial Transplant (2002) 0.82
Increased pheromone cCF10 expression in Enterococcus faecalis biofilm formed by isolates from renal transplant patients. Curr Microbiol (2012) 0.82
Is there any relationship between lipids and vitamin B levels in persons with elevated risk of atherosclerosis? Med Sci Monit (2003) 0.81
Posttransplant encapsulating peritoneal sclerosis: presentation of cases and review of the literature. J Nephrol (2012) 0.81
Flow cytometric analysis of STAT5 phosphorylation and CD95 expression in CD4+ T lymphocytes treated with recombinant human erythropoietin. J Recept Signal Transduct Res (2011) 0.81
Autosomal dominant polycystic kidney disease is not a risk factor for post-transplant diabetes mellitus. Matched-pair design multicenter study. Arch Med Res (2007) 0.81
Atorvastatin improves tubular status in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study. Acta Biochim Pol (2010) 0.80
Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease. Am J Hypertens (2012) 0.80
Carnitine content in different muscles of patients receiving maintenance hemodialysis. J Ren Nutr (2007) 0.80
The effect of N-acetylcysteine on proteinuria and markers of tubular injury in non-diabetic patients with chronic kidney disease. A placebo-controlled, randomized, open, cross-over study. Kidney Blood Press Res (2008) 0.80
Treatment with recombinant human erythropoietin is associated with rejuvenation of CD8+ T cell compartment in chronic renal failure patients. Nephrol Dial Transplant (2007) 0.80
Effect of 12-month therapy with omega-3 polyunsaturated acids on glomerular filtration response to dopamine in IgA nephropathy. Am J Nephrol (2004) 0.79
Chronic food restriction differentially affects NPY mRNA level in neurons of the hypothalamus and in neurons that innervate liver. Neurosci Lett (2008) 0.79
Long-term therapy with recombinant human erythropoietin increases CD8+ T-cell apoptosis in haemodialysis patients. Nephrol Dial Transplant (2004) 0.79
[Sensitivity for antibiotics among the E. coli strains isolated from patients with different clinical stage of infection]. Przegl Lek (2012) 0.79
Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation. Ann Acad Med Stetin (2008) 0.79
High level of negative emotions in hemodialysis patients suggests the need for therapy. Nephron (2002) 0.79
Uric acid excretion and dopamine-induced glomerular filtration response in patients with IgA glomerulonephritis. Am J Nephrol (2007) 0.79
Does CMV infection impact the virulence of Enterococcus faecalis? Virulence (2013) 0.79
The effect of N-acetylcysteine on blood pressure and markers of cardiovascular risk in non-diabetic patients with chronic kidney disease: a placebo-controlled, randomized, cross-over study. Med Sci Monit (2010) 0.78
[Genetic predisposition to systemic complications of arterial hypertension in maintenance haemodialysis patients]. Pol Merkur Lekarski (2008) 0.78
Risk factors for selective cognitive decline in dialyzed patients with end-stage renal disease: evidence from verbal fluency analysis. J Int Neuropsychol Soc (2011) 0.78
Nicotinamide metabolites accumulate in the tissues of uremic rats. J Ren Nutr (2008) 0.78
Influence of megestrol acetate on nutrition and inflammation in dialysis patients - preliminary results. Acta Biochim Pol (2009) 0.77
[Influence of erythropoietin on immunological system of patients with chronic renal failure]. Pol Merkur Lekarski (2003) 0.77
Tubular injury: the first symptom of hypertensive kidney involvement? Med Sci Monit (2003) 0.77
Vitamin B6 and the immunity in kidney transplant recipients. J Ren Nutr (2012) 0.77
Decrease of serum chemerin concentration in patients with end stage renal disease after successful kidney transplantation. Regul Pept (2011) 0.77
Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis. Med Sci Monit (2005) 0.77
[Early diagnosis of renal diseases--preliminary results from the pilot study PolNef]. Przegl Lek (2005) 0.77
Treatment of hypertension in chronic kidney disease patients under specialized care: one-center cross-sectional analyses. Blood Press (2014) 0.77
[The effect of therapy with small doses of mega-3 polyunsaturated fatty acid on renal reserve and metabolic disturbances in patients with primary IGA glomerulopathy]. Pol Arch Med Wewn (2002) 0.77
Determinants of anxiety in patients with advanced somatic disease: differences and similarities between patients undergoing renal replacement therapies and patients suffering from cancer. Int Urol Nephrol (2012) 0.77
Effect of aliskiren on proteinuria in non-diabetic chronic kidney disease: a double-blind, crossover, randomised, controlled trial. Int Urol Nephrol (2012) 0.77
Dual blockade of the renin-angiotensin-aldosterone system with high-dose angiotensin-converting enzyme inhibitor for nephroprotection: an open, controlled, randomized study. Scand J Urol Nephrol (2008) 0.77
[Program of early diagnosis of chronic renal disease in children--SopKard 15 nephrological project]. Pol Merkur Lekarski (2008) 0.76
Benefits and menaces related to the use of statins in patients after renal transplantation. Ann Transplant (2002) 0.76
[Vitamins and microelements in patients with chronic kidney disease]. Wiad Lek (2014) 0.76
Beneficial effect of treatment with cyclosporin A in a case of refractory antisynthetase syndrome. Rheumatol Int (2007) 0.76
The enhanced renin-angiotensin-aldosteron system pharmacological blockade--which is the best?. Kidney Blood Press Res (2012) 0.76
Urinary tract infections during the first year after renal transplantation: one center's experience and a review of the literature. Clin Transplant (2014) 0.76
[Life threatening drug-induced hyperkaliemia--case report]. Pol Arch Med Wewn (2006) 0.75
Initiation of dialysis--the right timing and the right tools. Nephrol Dial Transplant (2009) 0.75
Megestrol acetate use in hypoalbuminemic dialysis patients. J Ren Nutr (2011) 0.75
Dual blockade of the renin-angiotensin-aldosterone system in renal disease: what is the future? Authors' reply. Pol Arch Med Wewn (2014) 0.75
Influence of megestrol acetate on nutrition, inflammation and quality of life in dialysis patients. Int Urol Nephrol (2011) 0.75
[Pathogenetic and epidemiological aspects of hypertensive nephropathy]. Pol Arch Med Wewn (2003) 0.75
[Peritoneal dialysis as an alternative in the treatment of patient with heart failure refractory to conventional therapy]. Kardiol Pol (2013) 0.75
[Isoprostanes - important marker of the oxidative stress estimation in patients with chronic kidney disease]. Pol Merkur Lekarski (2013) 0.75
[Mycophenolate mofetil--20 years of experience in treatment of rheumatic diseases]. Postepy Hig Med Dosw (Online) (2015) 0.75
[The nephrological knowledge of patricipants of World Kidney Day 2012 in Gdańsk center]. Wiad Lek (2014) 0.75
A single-center experience of renal transplantation in elderly patients: a paired-kidney analysis. Transplantation (2007) 0.75
[Late drug-induced hyperkalemia in a patient with congestive heart failure]. Przegl Lek (2005) 0.75
Effectiveness of antihypertensive treatment in patients with chronic kidney disease. J Ren Nutr (2008) 0.75
Thiamine Diphosphate Status and Dialysis-Related Losses in End-Stage Kidney Disease Patients Treated with Hemodialysis. Blood Purif (2017) 0.75
[Estimation of the frequency of occurrence of microorganisms isolated from blood cultures of hospitalized patients in the Hospital of Medical University in Gdańsk in 2000-2002]. Przegl Epidemiol (2007) 0.75
[Endothelial dysfunction in peritoneal dialysis patients and its relationship to nutrition]. Pol Merkur Lekarski (2006) 0.75
Activities of lipogenic enzymes in subcutaneous adipose tissue are not increased in patients with chronic kidney failure. Pol Arch Med Wewn (2012) 0.75
[Molecular mechanism of fatty acids impact on plasma lipid profile (part II)]. Przegl Lek (2007) 0.75
[Encapsulating peritoneal sclerosis--a serious complication of peritoneal dialysis with not characteristic symptoms]. Wiad Lek (2006) 0.75
[Molecular mechanism of fatty acids impact on plasma lipid profile (part I)]. Przegl Lek (2007) 0.75
Manual aspiration thrombectomy complemented with local thrombolysis for acute renal artery embolism. Pol Arch Med Wewn (2015) 0.75
[Risk factors for skin cancer development in patients after organ transplantation]. Postepy Hig Med Dosw (Online) (2012) 0.75
Discontinuation of mycophenolate mofetil from a tacrolimus-based triple regimen 2 months after renal transplantation: a comparative randomized, multicentre study. Transpl Int (2007) 0.75
[Renal replacement therapy in the elderly patients in the Gdansk Pomeranian region]. Przegl Lek (2002) 0.75
[The conjugated linoleic acids in prevention and treatment of obesity]. Przegl Lek (2007) 0.75
[Groin hernia in the patients receiving CAPD]. Wiad Lek (2005) 0.75
[The evaluation of mineral crystallinity of mandibular bone tissue using electron paramagnetic resonance (EPR) in patients suffering from renal osteodystrophy]. Przegl Lek (2006) 0.75
Regression of long standing anorexia nervosa following acute renal failure caused by gentamicin intoxication. Przegl Lek (2005) 0.75
The history of nephrology in Poland. J Nephrol (2006) 0.75
[Preliminary treatment outcome of cardiovascular operations in patients with dialysis-dependent renal failure]. Kardiol Pol (2004) 0.75
Bioelectrical impedance analysis before versus after a hemodialysis session in evaluation of nutritional status. J Ren Nutr (2006) 0.75